GGenetics Read More New Meta-Analysis Demonstrates that Access to the GeneSightSeptember 3, 2025 SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular…
MMedication Read More Anticoagulants in AF Post-ICH: The Dilemma ContinuesJuly 21, 2025 TOPLINE: In patients with atrial fibrillation (AF) with a recent episode of intracranial hemorrhage (ICH), the use of…